Central Nervous System Diseases

We are an academic Contract Research Organisation (CRO) devoted to executing clinical trials for CNS diseases in the most effective manner possible. We put science first, and it shows in every trial.

We approach every study with a mindset focused on solving clients’ challenges with tailored solutions and expertise specific to our CNS focus areas: Amyotrophic Lateral Sclerosis (ALS), Alzheimer’s Disease, Epilepsy, Parkinson’s Disease and Hearing Loss (ENT).

Meet our scientific leaders for CNS trials

Prof. dr. Leonard van den Berg, neurologist at University Medical Centre (UMC) Utrecht and ALS Centrum. He is experienced in conducting global ALS trials, established the prominent TRICALS site network, and is chair of the European Network for the Cure of ALS.

Meet our scientific leaders for CNS trials

Prof. dr. Anne Schilder, Ear Institute at University College London (UCL) senior investigator and leader of NIHR UCLH Biomedical Research Centre’s programme for translational hearing. She is a world leader in ENT research.

Meet our scientific leaders for CNS trials

Prof. dr. Eugen Trinka, chair of the neurology department at Paracelsus Medical University Salzburg and the Austrian Society of Neurology’s president-elect.

Meet our scientific leaders for CNS trials

Professor John Harrison, Chief Scientific Officer at Scottish Brain Sciences, is a renowned cognition expert with 25 years of experience in aiding over 80 CNS drug development organizations. His contributions include developing the Neuropsychological Test Battery for Alzheimer’s studies and playing a pivotal role in Brintellix’s development and registration. As an Associate Professor at AUmc Alzheimer Center and Visiting Professor at King’s College London, he holds Chartered Psychologist status and has authored over 100 books and scientific articles.

Meet our scientific leaders for CNS trials

Dr. Cris Lanting, clinical physicist-audiologist, as well as a paediatric audiologist at Radboud University Medical Center (UMC).

Meet our scientific leaders for CNS trials

Dr. Jort Vijverberg, a neurologist at the Brain Research Center and a senior researcher at Alzheimercentrum Amsterdam. He has been the principal investigator on many Alzheimer’s clinical trials and consults with the pharmaceutical industry.

Highlighted trials

Brain Clinical is our proprietary network for CNS trials, providing experienced investigators and sites for CNS clinical trials.


The Brain Research Center is a specialised team of doctors, nurses, and neuropsychologists who are focused on client needs. They have extensive experience conducting clinical trials and have connections to innovative drug developers around the globe.

Read more

TRICALS, the largest European research initiative to find a cure for ALS, includes 48 top research centres in 16 countries. They are highly experienced in this area, providing efficient trial design and expert study oversight.

Read more

European Collaboration for Epilepsy Trials (ECET) is a group of expert scientists collaborating inside the Epilepsy Alliance Europe framework. They help provide access to epilepsy-focused centres and specialists.

Read more

We leverage our unique triangle of Science, Networks, and Operational excellence to run efficient trials across our CNS areas of expertise. A prime example is the SAPHIR study.

 

 

In the SAPHIR study, we helped the Sponsor fine-tune their protocol and identify specialised sites to overcome recruitment challenges. We ultimately helped them find 120 patients at 24 sites and streamline their project’s path to completion.


Our in-house expert CNS team

Our operational team members average many years of experience running efficient central nervous system trials that deliver high- quality data for Julius Clinical’s Sponsors.

Lieza exalto
Maria papakrasa

Related webinars

Webinar: Real-World Data in ALS

On 30 May, we hosted the webinar "Real-World Data in ALS", in which we explored the innovative integration of Real World Data (RWD) in clinical trials for Amyotrophic Lateral Sclerosis (ALS). As a critical step forward in the pursuit of effective ...

CNS resources

Explore our CNS capabilities, studies, and other resources.

Download

"*" indicates required fields

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Request for proposal

"*" indicates required fields

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
This field is for validation purposes and should be left unchanged.

Share

Twitter Facebook LinkedIn